Iron infusions are recommended when ferritin is low enough to cause symptoms or anemia and oral iron supplements have either failed, caused intolerable side effects, or cannot be absorbed properly. That covers a surprisingly wide range of people, from those with inflammatory bowel disease and chronic kidney disease to pregnant women in their second or third trimester and patients preparing for major surgery. The decision is rarely just about a single ferritin number; it depends on the underlying cause of the deficiency, how your body handles oral iron, and how urgently your iron stores need to be rebuilt.
What “Low Ferritin” Actually Means in Clinical Practice
Ferritin is a protein that stores iron, and measuring it in your blood is the most reliable way to estimate how much iron your body has in reserve. But the threshold for “low” is not as straightforward as you might expect. The World Health Organization historically defined low ferritin as below 15 µg/L for adults, but in clinical practice, iron deficiency is now commonly diagnosed when ferritin drops below 30 µg/L.1Clinical Medicine. Iron deficiency without anaemia: a diagnosis that matters Recent efforts have pushed to formally raise that lower limit to at least 30 ng/mL for diagnostic purposes.2Clinical Chemistry. A-159 Re-evaluating Ferritin Cutoffs for the Diagnosis of Iron Deficiency and Iron Deficiency Anemia A large U.S. population study defined absolute iron deficiency the same way: ferritin below 30 ng/mL.3JAMA Network Open. Absolute and Functional Iron Deficiency in the US, 2017-2020
The complication is that ferritin rises in response to inflammation, infection, and liver disease, regardless of whether your iron stores are actually adequate. Someone with rheumatoid arthritis or Crohn’s disease might have a ferritin of 80 µg/L and still be iron deficient, because chronic inflammation is artificially inflating that number. In these situations, clinicians raise the diagnostic cutoff to 100 µg/L, and use transferrin saturation below 20% as a complementary marker.1Clinical Medicine. Iron deficiency without anaemia: a diagnosis that matters Without accounting for inflammation, many genuinely iron-deficient patients would be told their labs look fine.
It is also worth noting that you can be iron deficient without being anemic. This condition, sometimes called non-anaemic iron deficiency, shows up as low ferritin and low transferrin saturation with a normal hemoglobin concentration.4PubMed Central. Non-anaemic iron deficiency People in this category often have fatigue, brain fog, hair thinning, and exercise intolerance. Whether they need an infusion depends on how severe their symptoms are and whether oral iron corrects the problem.
Why Oral Iron Fails for Many People
Iron tablets are cheap, widely available, and the standard first-line treatment. So why do so many people end up needing an infusion instead? The short answer is that oral iron is hard on the gut and unreliable in the conditions where iron deficiency is most common.
About four in ten patients prescribed oral iron do not take it consistently or for the recommended duration, and gastrointestinal side effects are a primary driver of that non-adherence.5PubMed Central. Medication adherence to oral iron therapy in patients with iron deficiency anemia Nausea, constipation, cramping, and dark stools are common complaints. Some people tolerate one brand but not another, or do better with every-other-day dosing, but a significant minority simply cannot get through a full course.
The other problem is absorption. Your body regulates iron uptake through a hormone called hepcidin, which acts as a gatekeeper in the gut. When inflammation is present, hepcidin levels rise and effectively block iron from crossing the intestinal wall into the bloodstream.6PubMed Central. Hepcidin and Iron in Health and Disease This is why oral iron often does not work well in people with chronic inflammatory conditions: the very disease causing the iron deficiency also prevents the treatment from being absorbed. Intravenous iron sidesteps this barrier entirely by delivering iron directly into the bloodstream.
Inflammatory Bowel Disease
Iron deficiency is one of the most common complications of Crohn’s disease and ulcerative colitis, driven by a combination of chronic bleeding, poor nutrient absorption, and persistent gut inflammation. Oral iron can actually worsen GI symptoms in these patients, and the inflamed intestinal lining absorbs it poorly in the first place.
For people with active disease flares or more severe anemia, intravenous iron is the preferred treatment. A systematic review found that IV iron can be safely given even during active disease and alongside biologic therapies, and that it is clearly preferable to oral iron in patients with aggravated anemia or disease flares because inflammation hampers intestinal iron absorption.7PubMed Central. Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review For patients in remission with only mild deficiency, oral iron remains a reasonable starting point, provided they tolerate it. But in practice, many IBD patients eventually require IV iron at some stage of their treatment.
Although European guidelines have made IV iron the standard of care for IBD-related iron deficiency, actual prescribing patterns still favor oral iron in many settings, partly because clinicians remain cautious about hypersensitivity reactions.8PubMed Central. Iron Therapy in Inflammatory Bowel Disease That gap between guideline and practice is slowly closing, but it means some IBD patients wait longer than necessary for effective treatment.
Chronic Kidney Disease and Dialysis
The kidneys play a central role in producing erythropoietin, the hormone that stimulates red blood cell production. When kidney function declines, erythropoietin drops, and iron demand rises as clinicians try to compensate with erythropoiesis-stimulating agents. On top of that, chronic kidney disease raises hepcidin levels, reducing oral iron absorption, and many patients experience GI side effects that make oral supplements impractical.9PubMed Central. Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
For patients on hemodialysis, intravenous iron is essentially routine. A large randomized trial compared a proactive high-dose IV iron sucrose strategy (up to 400 mg monthly unless ferritin exceeded 700 µg/L or transferrin saturation reached 40%) against a reactive low-dose approach that gave iron only when ferritin dropped below 200 µg/L or transferrin saturation fell below 20%.10PubMed. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis The proactive strategy reduced the need for erythropoiesis-stimulating agents and blood transfusions. For people with advanced kidney disease, the question is rarely whether to use IV iron but how aggressively to dose it.
Heart Failure
Iron deficiency is remarkably common in people with heart failure, even when they are not anemic by standard measures. The heart is a metabolically hungry organ, and when iron stores run low, cardiac muscle function and exercise tolerance decline. Clinical trials over the past decade have shown that correcting iron deficiency with IV iron in heart failure patients improves symptoms, exercise capacity, and quality of life, and reduces hospitalizations.
This evidence was strong enough that both U.S. and European heart failure guidelines now recommend IV iron for patients with heart failure and confirmed iron deficiency.11PubMed Central. Multidisciplinary approach to implementing ferric carboxymaltose for IV iron replacement in heart failure with iron deficiency Ferric carboxymaltose is specifically indicated for this population. Oral iron has not shown the same benefits in heart failure trials, partly because the absorption issues described earlier are especially pronounced in patients with the fluid overload and gut congestion that accompany heart failure.
Heavy Menstrual Bleeding and Postpartum Anemia
Heavy periods are one of the most common causes of iron deficiency in premenopausal women, and the iron lost each month can outpace what oral supplements can replenish. The usual approach is to start with oral iron, but there is no formal guidance on when to switch to IV iron in this population, leaving many women in a frustrating cycle of partial correction and recurring deficiency.12PubMed Central. Iron deficiency anemia in patients with heavy menstrual bleeding: The patients’ perspective from diagnosis to treatment
A cost-effectiveness analysis modeling women aged 18 to 51 with heavy menstrual bleeding found that starting with IV iron dextran as first-line treatment was actually the cost-effective strategy compared to oral ferrous sulfate, yielding better quality-adjusted outcomes at a reasonable incremental cost.13PubMed Central. Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding That finding challenges the assumption that oral iron should always come first and raises the question of whether some women would be better served by skipping the trial-and-error phase entirely.
After childbirth, the picture is similar. A cost-effectiveness model of postpartum anemia estimated that IV iron prevented hundreds of thousands of persistent anemia cases and tens of thousands of postpartum depression cases across a large cohort, with an acceptable cost per quality-adjusted life year gained.14American Journal of Obstetrics & Gynecology. IV versus oral iron for postpartum anemia: A cost-effectiveness analysis For new mothers dealing with exhaustion and mood changes, the speed with which IV iron restores hemoglobin can be meaningful.
Pregnancy
Iron demands surge during pregnancy to support expanded blood volume and fetal growth. Many pregnant women become iron deficient even with prenatal vitamins, and those who develop moderate-to-severe anemia face risks including preterm delivery and low birth weight. IV iron is considered safe and effective during the second and third trimesters, though it is generally avoided in the first trimester due to limited safety data in early gestation.15PubMed Central. The Incidence, Complications and Treatment of Iron Deficiency in Pregnancy
When IV iron is needed during pregnancy, ferric carboxymaltose and iron sucrose are the two most studied options. A comparative trial found that both had similar safety profiles, though ferric carboxymaltose can be given in larger doses per session, meaning fewer visits to the infusion center.16Indian Journal of Obstetrics and Gynecology Research. A comparative study of efficacy, safety and compliance of intravenous ferric carboxymaltose versus iron sucrose in the treatment of iron deficiency anaemia of pregnancy For pregnant women who cannot tolerate oral iron or whose anemia is too severe for pills to correct in time, IV iron is the standard second-line approach.
Before Surgery
Going into a major operation with low hemoglobin increases the likelihood of needing a blood transfusion, which carries its own risks and costs. Preoperative iron infusion is becoming a standard part of patient blood management programs designed to reduce transfusion rates. A Cochrane review noted that parenteral iron preparations are more effective at rapidly correcting iron stores than oral supplements in conditions requiring urgent correction.17PubMed Central. Iron therapy for pre-operative anaemia
A randomized trial in patients with preoperative anemia found that IV iron roughly doubled the proportion who had their anemia corrected before surgery compared to placebo.18The Lancet. Preoperative intravenous iron to treat anaemia in major surgery A more recent study of ferric derisomaltose in abdominal surgery patients showed a mean hemoglobin increase of nearly 1.9 g/dL within three to four weeks, with even larger gains in those with more severe starting anemia.19PubMed. Intravenous ferric derisomaltose for preoperative anemia in abdominal surgery The practical upshot is that if you have scheduled surgery and your hemoglobin is low, your surgeon or anesthesiologist may order an iron infusion several weeks beforehand to optimize your blood counts.
After Bariatric Surgery
Weight loss surgeries that rearrange the digestive tract, especially Roux-en-Y gastric bypass, create a permanent reduction in the surface area available to absorb nutrients. Iron is normally absorbed in the duodenum, which is largely bypassed after this procedure. As a result, iron deficiency can develop months or years later, even with oral supplementation.
One study found that about 22% of anemic patients after gastric bypass were intolerant of or unresponsive to oral iron and required IV iron infusion, typically several years after the original surgery.20PubMed Central. Anemia and the Need for Intravenous Iron Infusion after Roux-en-Y Gastric Bypass Because these patients fundamentally lack the anatomy needed to absorb oral iron efficiently, IV infusions often become a recurring part of their long-term care rather than a one-time fix.21Surgery for Obesity and Related Diseases. Efficacy and safety of intravenous iron dextran infusion in the treatment of iron deficiency anemia after Roux-en-Y gastric bypass
Restless Legs Syndrome
Restless legs syndrome, that maddening urge to move your legs at rest, has a well-established link to low brain iron levels. Many people with RLS have low ferritin, and raising those iron levels can dramatically reduce symptoms. Oral iron sometimes helps, but it is slow, and brain iron levels do not always respond reliably to oral supplementation.
A trial of ferric carboxymaltose in patients with iron deficiency anemia and RLS found that symptoms improved significantly within six weeks. MRI imaging showed measurable increases in iron content in brain structures associated with RLS, including the thalamus and substantia nigra, and those iron changes correlated with symptom improvement.22PubMed Central. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia Pregnant women with RLS and low ferritin have also responded well to IV iron sucrose, experiencing substantial symptom relief and improved sleep quality.23PubMed. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin For someone whose sleep is severely disrupted by RLS and whose ferritin is low, an infusion can be life-changing in a way that months of oral iron tablets might not achieve.
Quality of Life in Cancer Patients
Cancer-related iron deficiency is driven by a combination of chronic inflammation, blood loss from tumors, and the effects of chemotherapy on blood cell production. The fatigue that accompanies it is often dismissed as an expected part of cancer treatment, but it meaningfully worsens quality of life and functional capacity.
A prospective study of IV iron in cancer patients with iron deficiency found that while the improvement in physical walking distance did not quite reach statistical significance, patient-reported measures told a different story. Scores in physical functioning, vitality, and emotional well-being all improved significantly after IV iron treatment.24Scientific Reports. A prospective study of intravenous iron effectiveness on quality of life and functional outcomes in patients with cancer When you are dealing with cancer treatment, even a partial restoration of energy and emotional resilience carries real weight.
Safety Concerns Worth Knowing About
The biggest worry people have about iron infusions is allergic reactions. True anaphylaxis to modern IV iron formulations is rare, and most acute reactions are not classic allergic responses at all. They are more commonly a phenomenon called complement activation-related pseudo-allergy, triggered by the iron nanoparticles themselves rather than by an immune antibody response. Risk factors for a reaction include a previous reaction to IV iron, fast infusion rates, multiple drug allergies, and severe atopy.25PubMed Central. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management Infusion centers now monitor patients during and after administration, and the risk profile of newer formulations is considerably better than older iron dextran products.
A less well-known side effect is hypophosphatemia, a drop in blood phosphate levels that occurs primarily with ferric carboxymaltose. The mechanism involves a bone-derived hormone called FGF23: certain IV iron formulations prevent FGF23 from being broken down normally, which triggers the kidneys to waste phosphate in the urine. This effect is almost exclusively seen with ferric carboxymaltose and is negligible with iron dextran or ferumoxytol, and low but not negligible with iron sucrose or ferric derisomaltose.26PubMed Central. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome For most people receiving a single infusion course, this is clinically insignificant. But for patients needing repeated doses of ferric carboxymaltose, monitoring phosphate levels matters, because prolonged hypophosphatemia can cause bone pain and muscle weakness.
Regarding premedication with antihistamines or steroids before infusions: this practice was once common but is increasingly being abandoned. A quality improvement project at a major hospital system reduced premedication use from about 5% to under 1% of infusions through staff education, with no increase in hypersensitivity reactions.27Blood. Reducing premedication use with intravenous iron in the outpatient setting: A quality improvement project Current evidence suggests routine premedication is unnecessary with modern formulations and may even complicate the clinical picture by masking early signs of a genuine reaction.
How Different IV Iron Formulations Compare
Not all IV iron products are the same, and the differences go beyond branding. Each formulation is a nanoparticle complex of iron wrapped in a carbohydrate shell, and the specific shell chemistry determines how quickly the body processes the iron, how much can be given per session, and what side effects to expect.28PubMed Central. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics
The main products you will encounter in practice include:
- Iron sucrose: One of the most widely used formulations globally, given in smaller doses (typically 200–300 mg per session), requiring multiple visits to complete a full repletion course. Well-studied in pregnancy and kidney disease.
- Ferric carboxymaltose: Can deliver up to 750 mg in a single sitting, reducing the number of infusion visits. Specifically indicated for heart failure with iron deficiency. The main downside is the risk of phosphate drops described above.
- Low-molecular-weight iron dextran: Can deliver a full replacement dose (often 1,000 mg or more) in one session. Historically associated with anaphylaxis concerns, though the low-molecular-weight versions have a much better safety record than older high-molecular-weight products. Emerged as the cost-effective first-line IV option in at least one modeling study of heavy menstrual bleeding.
- Ferric derisomaltose (iron isomaltoside): Similar to iron dextran in allowing high single-session doses, with a low hypophosphatemia risk. Increasingly studied in preoperative settings.
- Ferumoxytol: Can be given as a rapid injection rather than a prolonged drip, which is convenient but requires monitoring for rare but serious reactions. Often used in kidney disease settings.
The choice among these depends on your specific condition, how much iron you need, how many infusion visits are practical for you, and your clinician’s familiarity and comfort level with each product. There is no single “best” IV iron; the right one is the one that matches your clinical scenario and logistics.
What Happens After the Infusion
Most people feel fine immediately after an iron infusion, though some experience mild flushing, a metallic taste, or muscle aches for a day or two. A phenomenon sometimes called the “Fishbane reaction,” which involves flushing, chest tightness, and back pain during infusion of iron sucrose or iron dextran, is self-limiting and does not represent true allergy. It typically resolves simply by slowing the infusion rate.
Ferritin levels can spike dramatically in the days following an infusion, sometimes climbing above 1,000 ng/mL, which alarms patients who check their labs too early. This spike does not reflect true iron overload. It represents the body processing and distributing the large bolus of iron it just received. Most clinicians wait at least six to eight weeks before rechecking ferritin to get a meaningful picture of whether the infusion adequately replenished stores. Hemoglobin typically starts rising within two to three weeks, though the full effect takes longer.
How long the effect lasts depends entirely on why you were iron deficient. If the underlying cause has been addressed, like surgery for fibroids that were causing heavy bleeding, one infusion course may be all you need. If the cause is ongoing, as in chronic kidney disease or a malabsorptive condition after bariatric surgery, you may need periodic infusions indefinitely. Monitoring your ferritin and hemoglobin over time, rather than treating a single lab result in isolation, is how your doctor determines whether and when you need another round.